Yue-juan Zheng

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
All-trans retinoic acid (ATRA) is a revolutionary agent for acute promyelocytic leukemia (APL) treatment via differentiation induction. However, ATRA treatment also increases cytokine, chemokine, and adhesive molecule (mainly ICAM-1) expression, which can cause clinical complications, including a severe situation known as differentiation syndrome (DS) which(More)
  • 1